Literature DB >> 6736368

Streak artefacts of the thoracic aorta: pseudodissection.

S Gallagher, A K Dixon.   

Abstract

Streak artefacts running across images of the aorta can mimic aortic dissection on CT. We have compared 12 patients suffering from dissection with 45 others. Some artefacts were found in every patient. Such misleading appearances were more obtrusive in dissectors. However, we have found several pointers that help distinguish true intimal flaps from artefacts. Flaps are usually thin structures showing mild curvature. Artefacts are generally linear and vary in thickness. Their orientation may change markedly from one CT section to the next; they frequently extend beyond the confines of the aorta. In the ascending aorta, artefacts usually run at an angle of approximately 66 degrees to the coronal plane; especial care should be taken before diagnosing a straight intimal flap in that orientation. Careful study of images on the monitor rather than on film is a further help in the important distinction between artefact and intimal flap.

Entities:  

Mesh:

Year:  1984        PMID: 6736368     DOI: 10.1097/00004728-198408000-00018

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  3 in total

1.  Radiological evaluation of the ascending aorta following repair of type A dissection.

Authors:  J Slavotinek; S W Kendall; C D Flower; A K Dixon; F C Wells; S R Large
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Sep-Oct       Impact factor: 2.740

2.  Pseudo-dissection of ascending aorta in inferior myocardial infarction.

Authors:  Muhammad Nadeem Attar; Hossam Elmahy; Grahame K Goode
Journal:  Heart Int       Date:  2011-06-09

3.  A low threshold to ECG-gated repeat CTA reduces the risk of false-positive diagnosis of type A dissection in interhospital referrals: a case series study.

Authors:  Angela Kornberger; Iris Burck; Hazem El Beyrouti; Nancy Halloum; Andres Beiras-Fernandez; Christian-Friedrich Vahl
Journal:  Ther Clin Risk Manag       Date:  2018-10-17       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.